Although direct evidence for its ligand-dependent coregulator function with ESR1 in this disease remains limited, studies in ESR1-positive breast cancers have shown that ZMIZ1 participates in the ESR1 chromatin-bound complex to enhance the expression of cell cycle regulators such as E2F2. Here, E2F2 is linked to breast cancer.